O2 RegenTech

O2 RegenTech

Early Stage

Healing Chronic Wounds

Healing Chronic Wounds


Raised to Date: Raised: $0

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)



Reporting Date


Days Remaining


% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Akron, Ohio

O2 RegenTech, with a valuation of $6.8 million, is raising funds on NetCapital. The company is using its proprietary biopolymer technology to commercialize easy-to-use wound care solutions. O2 RegenTech’s first product is called OXAID and is a moist, oxygenating, and antimicrobial dressing that promotes chronic wound healing. It is a one-of-a-kind wound solution that is cost-effective and easy to use and helps chronic wounds heal faster and at a lower cost than other oxygen delivery systems. Dr. Andreas Inmann and Dr. Nic Leipzig founded O2 RegenTech in July 2013. The current crowdfunding campaign has a minimum target of $10,002.80 and a maximum target of $612,000. The campaign proceeds will be used for product development, regulatory affairs, operations, payroll, and biocompatibility testing.

Summary Profit and Loss Statement

FY 2022 FY 2021












Net Income



Summary Balance Sheet

FY 2022 FY 2021




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 11/08/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
O2 RegenTech on NetCapital 2023
Platform: Netcapital
Security Type: Equity - Common
Valuation: $6,800,000
Price per Share: $6.80

Follow company

Follow O2 RegenTech on NetCapital 2023

Buy O2 RegenTech's Deal Report

O2 RegenTech Deal Report

Get KingsCrowd’s comprehensive report on O2 RegenTech including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether O2 RegenTech is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the O2 RegenTech deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge